Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Lung Cancer. 2009 May 26;67(3):366. doi: 10.1016/j.lungcan.2009.04.019

Table II.

Baseline values for performance characteristics of diagnostic modalities

Variable Sensitivity Baseline probability (range, %)
EUS FNA 69% (53-82%)[57]
EBUS FNA 69% (53-82%)[57]
TBNA 36% (22-52%)[57]
EUS FNA+EBUS FNA 93% (81-99%)[57]
EUS FNA+TBNA 79% (63-90%)[57]
EBUS FNA+TBNA 76% (61-88%)[57]
MED 95% (70-95%)[12,14,19,35,37-42]
Prevalence of MMLN 30% (0-50%)[57]

EUS = endoscopic ultrasound; FNA = fine needle aspiration; EBUS = endobronchial ultrasound; TBNA = transbronchial needle aspiration; MMLN = malignant mediastinal lymph nodes; MED = mediastinoscopy